BrightSpring Health Services (NASDAQ:BTSG) Price Target Raised to $35.00

BrightSpring Health Services (NASDAQ:BTSG) had its price objective boosted by UBS Group from $31.00 to $35.00 in a report released on Monday,Benzinga reports. The firm currently has a buy rating on the stock.

A number of other research firms have also recently commented on BTSG. Cowen restated a “buy” rating on shares of BrightSpring Health Services in a research report on Monday, August 4th. TD Cowen assumed coverage on BrightSpring Health Services in a report on Monday, June 23rd. They set a “buy” rating and a $37.00 target price for the company. Bank of America increased their target price on BrightSpring Health Services from $27.50 to $31.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of BrightSpring Health Services in a report on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft set a $30.00 target price on BrightSpring Health Services and gave the stock a “buy” rating in a report on Monday, September 8th. Nine equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $31.38.

BrightSpring Health Services Price Performance

BTSG opened at $30.74 on Monday. The company has a quick ratio of 1.34, a current ratio of 1.76 and a debt-to-equity ratio of 1.43. BrightSpring Health Services has a 12 month low of $14.73 and a 12 month high of $31.95. The company has a fifty day simple moving average of $25.89 and a 200 day simple moving average of $22.50. The stock has a market cap of $5.45 billion, a P/E ratio of 99.16, a P/E/G ratio of 0.50 and a beta of 2.40.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings data on Friday, August 1st. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. BrightSpring Health Services had a net margin of 0.55% and a return on equity of 9.29%. The business had revenue of $3.15 billion during the quarter, compared to analysts’ expectations of $2.99 billion. During the same quarter in the prior year, the company earned $0.10 EPS. The firm’s quarterly revenue was up 15.3% on a year-over-year basis. BrightSpring Health Services has set its FY 2025 guidance at EPS. On average, research analysts expect that BrightSpring Health Services will post 0.59 EPS for the current year.

Hedge Funds Weigh In On BrightSpring Health Services

A number of large investors have recently modified their holdings of the business. GAMMA Investing LLC grew its holdings in BrightSpring Health Services by 2,526.5% during the first quarter. GAMMA Investing LLC now owns 14,472 shares of the company’s stock worth $262,000 after purchasing an additional 13,921 shares during the period. Rhumbline Advisers grew its holdings in BrightSpring Health Services by 4.8% during the first quarter. Rhumbline Advisers now owns 77,100 shares of the company’s stock worth $1,395,000 after purchasing an additional 3,517 shares during the period. SG Americas Securities LLC grew its holdings in BrightSpring Health Services by 12.7% during the first quarter. SG Americas Securities LLC now owns 41,698 shares of the company’s stock worth $754,000 after purchasing an additional 4,698 shares during the period. Assenagon Asset Management S.A. bought a new position in BrightSpring Health Services during the first quarter worth about $561,000. Finally, Highland Capital Management LLC bought a new position in BrightSpring Health Services during the first quarter worth about $181,000.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.